Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Venture Life ( (GB:VLG) ) has shared an announcement.
Venture Life Group has repurchased 46,613 ordinary shares at a volume-weighted average price of 69.87 pence under its ongoing share buyback programme, with the shares to be held in treasury. The transaction, executed through Cavendish Capital Markets, reflects the company’s continued use of balance sheet resources to manage its capital structure and potentially enhance shareholder value.
Following this buyback, Venture Life now has 128,860,145 ordinary shares in issue, of which 5,411,250 are held in treasury, leaving 123,448,895 voting rights in the market. The updated voting rights figure provides shareholders with an important reference point for regulatory disclosure thresholds and may marginally increase existing investors’ proportional ownership and influence in the company.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £67.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Spark’s Take on GB:VLG Stock
According to Spark, TipRanks’ AI Analyst, GB:VLG is a Neutral.
Venture Life’s stock score is primarily supported by strong technical indicators and positive corporate events, such as share buybacks and insider buying, which suggest confidence in future prospects. However, the high P/E ratio and profitability challenges weigh down the score, indicating potential overvaluation and financial risks.
To see Spark’s full report on GB:VLG stock, click here.
More about Venture Life
Venture Life Group is an international consumer self-care company focused on proactive healthy longevity within the global consumer healthcare sector. Headquartered in the UK, it develops and commercialises products such as Balance Activ for women’s intimate health, Earol for ENT care, Lift and Glucogel for energy and glucose management, and Health & Her for the hormonal lifecycle, which are sold through pharmacies, health & beauty retailers, grocery chains and e-commerce channels worldwide.
Its products are typically recommended by pharmacists and healthcare practitioners and reach customers via a mix of direct supply to retailers in the UK, Ireland and the U.S., and international distribution partners elsewhere. This multi-channel, multi-geography approach positions Venture Life as a recognised player in the global self-care market, with a diversified brand portfolio across key consumer health categories.
Average Trading Volume: 323,252
Technical Sentiment Signal: Buy
Current Market Cap: £85.88M
For detailed information about VLG stock, go to TipRanks’ Stock Analysis page.